Soleno Therapeutics Inc (NASDAQ:SLNO)
| 0.182 Delayed Data As of 3:59pm ET |  -0.0029 / -1.57%Today’s Change | 0.13 Today|||52-Week Range 1.16 | -55.61% Year-to-Date |
Latest SLNO News | Press Releases
No recent news for Soleno Therapeutics Inc.
Today’s Trading
| Previous close | 0.18 |
| Today’s open | 0.18 |
| Day’s range | 0.18 - 0.18 |
| Volume | 13,698 |
| Average volume (3 months) | 1,139,104 |
| Market cap | $19.5M |
Data as of 3:59pm ET, 07/01/2022
Growth & Valuation
| Earnings growth (last year) | +1.52% |
| Earnings growth (this year) | +34.62% |
| Earnings growth (next 5 years) | +15.00% |
| Revenue growth (last year) | -- |
| P/E ratio | NM |
| Price/Sales | -- |
| Price/Book | 0.73 |
Competitors
| ---- | ||
| TPSTTempest Therapeutics... | +0.13 | +6.05% |
| NAVBNavidea Biopharmaceu... | -0.03 | -4.17% |
| VYNEVyne Therapeutics In... | +0.05 | +12.81% |
Data as of 3:59pm ET, 07/01/2022
Financials
| Next reporting date | August 11, 2022 |
| EPS forecast (this quarter) | -$0.06 |
| Annual revenue (last year) | $0.00 |
| Annual profit (last year) | -$30.9M |
| Net profit margin | -- |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters Redwood City, California |
Forecasts
